Table 3.
All indicators of the study population (n = 86)
| Variables | Preimplementation group (n = 43) |
Postimplementation group (n = 43) |
t/U /χ2 | P |
|---|---|---|---|---|
| SAP | 16 (37.2) | 6 (14.0) | 6.108 | 0.025* |
| Indicators of infection | ||||
| White blood cells (109/L) | 7.49 (5.51, 9.30) | 7.20 (5.51, 8.40) | 863.5 | 0.598 |
| Procalcitonin (ng/ml) | 0.083 (0.054, 0.095) | 0.054 (0.044, 0.076) | 610.5 | 0.007* |
| Hypersensitive C-reactive protein (mg/L) | 8.74 (4.56, 13.60) | 5.20 (3.40, 6.70) | 636.5 | 0.013* |
| Length of stay, days | 13 (9, 18) | 11 (8, 14) | 687.0 | 0.040* |
| Total cost, USD | 20,351.62 (12,794.51, 32,790.98) | 18,139.21 (12,658.4, 32,666.31) | 843.0 | 0.481 |
| NIHSS score | 4 (2, 13) | 6 (2, 9) | 923.0 | 0.990 |
| Aspiration | 16 (37.2) | 4 (9.3) | 9.382 | 0.004* |
| NRS-2002 | 2.549 | 0.171 | ||
| ≥ 3 | 32 (74.4) | 25 (58.1) | ||
| < 3 | 11 (25.6) | 18 (41.9) | ||
| Serum albumin (g/L) | 33.92 ± 2.90 | 35.83 ± 4.20 | −2.459 | 0.016* |
| Oral hygiene score | 19 (15, 21) | 15 (13, 18) | 530.5 | 0.001* |
| 30 ml water swallowing test | 6.766 | 0.149 | ||
| I | 2 (4.7) | 10 (23.3) | ||
| II | 15 (34.9) | 12 (27.9) | ||
| III | 16 (37.2) | 15 (34.9) | ||
| IV | 6 (14.0) | 4 (9.3) | ||
| V | 4 (9.3) | 2 (4.7) | ||
| The degree of dysphagia | 7.097 | 0.131 | ||
| 0 | 2 (4.7) | 10 (23.3) | ||
| 2 | 15 (34.9) | 12 (27.9) | ||
| 4 | 17 (39.5) | 16 (37.2) | ||
| 5 | 6 (14.0) | 4 (9.3) | ||
| 6 | 3 (7.0) | 1 (2.3) | ||
*The difference was statistically significant
Results are presented as n (%), mean ± standard deviation or median (interquartile range)
SAP stroke-associated pneumonia; NIHSS National Institutes of Health Stroke Scale; NRS nutrition risk screening